Related Experiment Video
Updated: Jul 11, 2026
10:24
A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
Translational control: a target for cancer therapy
Saritha C Thumma1, Robert A Kratzke
1The Division of Hematology-Oncology-Transplant, Department of Medicine, The University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Cancer Letters
|October 10, 2007
Summary
Cancer cells often disrupt cap-mediated translation, the standard protein synthesis method. Restoring this control in pre-clinical models reduces tumor potential, leading to new cancer therapies targeting this process.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- Cap-mediated translation is the primary pathway for protein synthesis in eukaryotic cells.
- Malignant cells frequently exhibit dysregulation of cap-mediated translation.
- Restoring normal translational control is linked to reduced tumorigenic potential in preclinical cancer models.
Purpose of the Study:
- To investigate the role of cap-mediated translation deregulation in cancer.
- To highlight the therapeutic potential of targeting translational control mechanisms in oncology.
Main Methods:
- Analysis of cap-mediated translation in various cancer models.
- Evaluation of preclinical models demonstrating the impact of restored translational control.
Main Results:
- Evidence of widespread cap-mediated translation dysregulation in cancer cells.
- Demonstration that normalizing translation can decrease tumor-forming capabilities in preclinical settings.
Conclusions:
- Cap-mediated translation is a critical process frequently altered in cancer.
- Targeting this pathway represents a promising strategy for novel cancer therapeutics.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:29Translational Regulation
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:24Regulation of Expression Occurs at Multiple Steps
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...